Oncology News

In this episode, host Shikha Jain, MD, speaks with George Sledge, MD, about patient feedback benefiting leadership decision-making, the future of precision medicine in oncology and more.

Rates of wellness visits and preventive health screenings remain below pre-COVID-19 pandemic levels, particularly among diverse groups, according to a recent study.

From 2000-2019, breast cancer incidence rates increased among women aged 20 to 49 years, with more elevated rates among non-Hispanic Black women aged 20 to 29 and 30 to 39 years, according to study findings published in JAMA Network Open.

Considering conflicting clinical guidelines, primary care providers should focus on individualized decision-making when deciding if and when a patient should be screened for breast cancer, according to experts.

Template # 16 Headline: Among UK women aged 50 to 64 years with breast cancer, mortality rates were//

Black men should consider early PSA screening for prostate cancer, ideally starting at age 40, according to recommendations presented at ASCO Genitourinary Cancers Symposium.

In this episode, host Shikha Jain, MD, speaks with Jan Kitajewski, PhD, about blending community need with scientific advancement, his role as the director of a cancer care center and more.

Women with ovarian cancer from underrepresented groups have a higher likelihood of in-hospital mortality vs. hospice mortality compared with their white counterparts, according to study results published in Obstetrics & Gynecology.

Breast cancer screening and treatments in 2019 were both associated with more than 50% reduction in U.S. breast cancer mortality compared with interventions utilized over 4 decades ago, according to analysis results published in JAMA.

In this edition, FDA places hold on cell therapy trial after patient death, selpercatinib delivers superior outcomes and more.